Log in

NASDAQ:GLYCGlycoMimetics News Headlines

$2.11
+0.03 (+1.44 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.94
Now: $2.11
$2.18
50-Day Range
$1.83
MA: $3.14
$4.37
52-Week Range
$1.82
Now: $2.11
$13.44
Volume436,151 shs
Average Volume411,686 shs
Market Capitalization$91.95 million
P/E RatioN/A
Dividend YieldN/A
Beta2.67

Headlines

GlycoMimetics (NASDAQ GLYC) News Headlines

Source:
DateHeadline
 Brokerages Expect GlycoMimetics Inc (NASDAQ:GLYC) to Announce -$0.35 EPS Brokerages Expect GlycoMimetics Inc (NASDAQ:GLYC) to Announce -$0.35 EPS
www.americanbankingnews.com - March 29 at 8:40 PM
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at CowenGlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at Cowen
www.americanbankingnews.com - March 28 at 6:18 AM
Global Sickle Cell Anemia Therapeutics Industry Analysis 2019 - Market Developments and Financials of Key Players - ResearchAndMarkets.com - Yahoo FinanceGlobal Sickle Cell Anemia Therapeutics Industry Analysis 2019 - Market Developments and Financials of Key Players - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - March 27 at 1:12 PM
Edited Transcript of GLYC earnings conference call or presentation 28-Feb-20 1:30pm GMT - Yahoo FinanceEdited Transcript of GLYC earnings conference call or presentation 28-Feb-20 1:30pm GMT - Yahoo Finance
finance.yahoo.com - March 24 at 11:36 PM
Edited Transcript of GLYC earnings conference call or presentation 28-Feb-20 1:30pm GMTEdited Transcript of GLYC earnings conference call or presentation 28-Feb-20 1:30pm GMT
finance.yahoo.com - March 24 at 11:36 PM
GlycoMimetics Inc (NASDAQ:GLYC) Given Average Recommendation of "Buy" by BrokeragesGlycoMimetics Inc (NASDAQ:GLYC) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 12 at 5:31 PM
Daniel Junius Is The Independent Director of GlycoMimetics, Inc. (NASDAQ:GLYC) And They Just Spent US$68k On SharesDaniel Junius Is The Independent Director of GlycoMimetics, Inc. (NASDAQ:GLYC) And They Just Spent US$68k On Shares
finance.yahoo.com - March 11 at 9:14 AM
Insider Buying: GlycoMimetics Inc (NASDAQ:GLYC) Director Acquires 20,000 Shares of StockInsider Buying: GlycoMimetics Inc (NASDAQ:GLYC) Director Acquires 20,000 Shares of Stock
www.americanbankingnews.com - March 10 at 8:22 PM
Chipotle Gets Queso Right the Second Time Around - NasdaqChipotle Gets Queso Right the Second Time Around - Nasdaq
www.nasdaq.com - March 5 at 9:06 AM
Stock Alert: Recro Pharma Loses 24% On Earnings, Outlook - NasdaqStock Alert: Recro Pharma Loses 24% On Earnings, Outlook - Nasdaq
www.nasdaq.com - March 5 at 9:06 AM
ABM Q1 Profit Up - NasdaqABM Q1 Profit Up - Nasdaq
www.nasdaq.com - March 5 at 9:06 AM
Moderna CEO Says Its Coronavirus Vaccine Will Be Affordable - NasdaqModerna CEO Says Its Coronavirus Vaccine Will Be Affordable - Nasdaq
www.nasdaq.com - March 4 at 8:00 PM
Why Designer Brands Stock Jumped Today - NasdaqWhy Designer Brands Stock Jumped Today - Nasdaq
www.nasdaq.com - March 4 at 8:00 PM
GlycoMimetics Inc (GLYC) Q4 2019 Earnings Call Transcript - Motley FoolGlycoMimetics Inc (GLYC) Q4 2019 Earnings Call Transcript - Motley Fool
www.fool.com - March 4 at 8:00 PM
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 - Business WireGlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 - Business Wire
www.businesswire.com - February 29 at 6:04 PM
BRIEF-Glycomimetics Reports Q4 Loss Per Share $0.34 - ReutersBRIEF-Glycomimetics Reports Q4 Loss Per Share $0.34 - Reuters
www.reuters.com - February 29 at 12:29 AM
GlycoMimetics: 4Q Earnings Snapshot - Yahoo FinanceGlycoMimetics: 4Q Earnings Snapshot - Yahoo Finance
finance.yahoo.com - February 28 at 2:28 PM
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 - StreetInsider.comGlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019 - StreetInsider.com
www.streetinsider.com - February 28 at 9:28 AM
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019
finance.yahoo.com - February 28 at 9:28 AM
GlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020 - Business WireGlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020 - Business Wire
www.businesswire.com - February 27 at 12:16 PM
GlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020 - Yahoo FinanceGlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020 - Yahoo Finance
finance.yahoo.com - February 25 at 2:14 PM
GlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020GlycoMimetics to Present at the Cowen and Company 40th Annual Health Care Conference 2020
finance.yahoo.com - February 25 at 9:13 AM
Chemotherapy Induced Neutropenia Pipeline Review - H1 2020 - ResearchAndMarkets.com - Yahoo FinanceChemotherapy Induced Neutropenia Pipeline Review - H1 2020 - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - February 19 at 2:27 PM
Pfizer axes license agreement with GlycoMimetics - Seeking AlphaPfizer axes license agreement with GlycoMimetics - Seeking Alpha
seekingalpha.com - February 11 at 2:31 PM
Wall Street Pros: These 3 Stocks Can Double Next Year - Yahoo FinanceWall Street Pros: These 3 Stocks Can Double Next Year - Yahoo Finance
finance.yahoo.com - February 6 at 2:35 PM
GlycoMimetics Advances GMI-1359 Program With Patent Issuance and FDA Designations - Business WireGlycoMimetics Advances GMI-1359 Program With Patent Issuance and FDA Designations - Business Wire
www.businesswire.com - February 5 at 7:59 AM
GlycoMimetics (GLYC) Advances GMI-1359 Program With Patent Issuance, FDA Designations - StreetInsider.comGlycoMimetics (GLYC) Advances GMI-1359 Program With Patent Issuance, FDA Designations - StreetInsider.com
www.streetinsider.com - February 4 at 7:50 PM
GlycoMimetics Reports First Patient With Advanced Breast Cancer Dosed In GMI-1359 Trial - BenzingaGlycoMimetics Reports First Patient With Advanced Breast Cancer Dosed In GMI-1359 Trial - Benzinga
www.benzinga.com - February 1 at 7:42 AM
First Patient With Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics GMI-1359First Patient With Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics' GMI-1359
www.businesswire.com - January 30 at 5:37 PM
First Patient With Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics GMI-1359 - Yahoo FinanceFirst Patient With Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics' GMI-1359 - Yahoo Finance
finance.yahoo.com - January 30 at 12:36 PM
First Patient With Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics' GMI-1359First Patient With Advanced Breast Cancer Receives First Dose in Clinical Trial of GlycoMimetics' GMI-1359
finance.yahoo.com - January 30 at 12:36 PM
Week In Review: 4 China Biopharmas Announce $100+ Million Deals In First Week Of 2020 - Seeking AlphaWeek In Review: 4 China Biopharmas Announce $100+ Million Deals In First Week Of 2020 - Seeking Alpha
seekingalpha.com - January 12 at 4:45 PM
GlycoMimetics out-licenses two programs in Greater China - Seeking AlphaGlycoMimetics out-licenses two programs in Greater China - Seeking Alpha
seekingalpha.com - January 6 at 3:26 PM
Md. biotech outlines path for blood cancer drug, including in China - Washington Business JournalMd. biotech outlines path for blood cancer drug, including in China - Washington Business Journal
www.bizjournals.com - January 6 at 3:26 PM
Md. biotech outlines path for blood cancer drug, including in ChinaMd. biotech outlines path for blood cancer drug, including in China
finance.yahoo.com - January 6 at 3:26 PM
GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater ChinaGlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China
finance.yahoo.com - January 6 at 10:25 AM
Hedge Funds Dropped The Ball On GlycoMimetics, Inc. (GLYC) - Yahoo FinanceHedge Funds Dropped The Ball On GlycoMimetics, Inc. (GLYC) - Yahoo Finance
finance.yahoo.com - December 19 at 4:26 PM
Hedge Funds Dropped The Ball On GlycoMimetics, Inc. (GLYC)Hedge Funds Dropped The Ball On GlycoMimetics, Inc. (GLYC)
finance.yahoo.com - December 19 at 11:25 AM
GlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019 - Business WireGlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019 - Business Wire
www.businesswire.com - November 29 at 1:20 PM
GlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019GlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019
finance.yahoo.com - November 29 at 1:20 PM
FDA Approves AZNs Calquence, GLYCs Data To Be Delayed, ENLV Withdraws Offering - NasdaqFDA Approves AZN's Calquence, GLYC's Data To Be Delayed, ENLV Withdraws Offering - Nasdaq
www.nasdaq.com - November 22 at 8:44 AM
Hepion Pharmaceuticals leads healthcare gainers; GlycoMimetics and OptiNose among losers - Seeking AlphaHepion Pharmaceuticals leads healthcare gainers; GlycoMimetics and OptiNose among losers - Seeking Alpha
seekingalpha.com - November 21 at 3:07 PM
GlycoMimetics sinks 20% after delaying trial top-line - Seeking AlphaGlycoMimetics sinks 20% after delaying trial top-line - Seeking Alpha
seekingalpha.com - November 21 at 3:07 PM
Edited Transcript of GLYC earnings conference call or presentation 7-Nov-19 1:30pm GMT - Yahoo FinanceEdited Transcript of GLYC earnings conference call or presentation 7-Nov-19 1:30pm GMT - Yahoo Finance
finance.yahoo.com - November 14 at 2:53 PM
Edited Transcript of GLYC earnings conference call or presentation 7-Nov-19 1:30pm GMTEdited Transcript of GLYC earnings conference call or presentation 7-Nov-19 1:30pm GMT
finance.yahoo.com - November 14 at 2:53 PM
GlycoMimetics to Present at Two Upcoming Investor Conferences - Business WireGlycoMimetics to Present at Two Upcoming Investor Conferences - Business Wire
www.businesswire.com - November 13 at 11:01 PM
GlycoMimetics to Present at Two Upcoming Investor ConferencesGlycoMimetics to Present at Two Upcoming Investor Conferences
finance.yahoo.com - November 13 at 1:00 PM
GlycoMimetics (GLYC) CEO Rachel King on Q3 2019 Results - Earnings Call TranscriptGlycoMimetics' (GLYC) CEO Rachel King on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 9 at 1:46 PM
GlycoMimetics Reports Third Quarter 2019 Financial Results and Recent Operational Developments - Business WireGlycoMimetics Reports Third Quarter 2019 Financial Results and Recent Operational Developments - Business Wire
www.businesswire.com - November 7 at 12:52 PM
GlycoMimetics Reports Third Quarter 2019 Financial Results and Recent Operational DevelopmentsGlycoMimetics Reports Third Quarter 2019 Financial Results and Recent Operational Developments
finance.yahoo.com - November 7 at 12:52 PM
This page was last updated on 4/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel